Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Executive Vice President | February 18, 2005 | February 23, 2005 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date February 18, 2005 · Filed February 23, 2005
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $46.34 · Expires 2015-02-17 | Direct | 91,600 |
Reported balance
After 2005-02-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2005-02-18 · Grant · Acquired 91,600 · Balance 91,600 F1: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Plan in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 30,534 on 02/18/06, 30,533 on 02/18/07, and 30,533 on 02/18/08. |
Filing footnotes · ownership attribution and instrument terms
F1: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Plan in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 30,534 on 02/18/06, 30,533 on 02/18/07, and 30,533 on 02/18/08.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 18, 2005 Filed Feb 23, 2005 22:49 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 91,600 | $0.00 Strike: $46.34 | $0.00 |
DisclosureSEC source: 0001104659-05-008012 · a4.xml · derivative · entry 1 DE LASA JOSE M · CIK 0001239418 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,600 Underlying: common shares · 91,600 shares Expires 2015-02-17 F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Plan in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 30,534 on 02/18/06, 30,533 on 02/18/07, and 30,533 on 02/18/08. F1 · kind: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Plan in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 30,534 on 02/18/06, 30,533 on 02/18/07, and 30,533 on 02/18/08. Read SEC document |
| February 14, 2005 Filed Feb 16, 2005 00:54 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 26,531 | $0.00 Strike: $46.20 | $0.00 |
DisclosureSEC source: 0001104659-05-006833 · a4.xml · derivative · entry 5 DE LASA JOSE M · CIK 0001239418 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,531 Underlying: common shares · 26,531 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 14, 2005 Filed Feb 16, 2005 00:54 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 31,922 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-05-006833 · a4.xml · derivative · entry 4 DE LASA JOSE M · CIK 0001239418 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,922 Underlying: common shares · 31,922 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 14, 2005 Filed Feb 16, 2005 00:54 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 26,531 | $46.20 | $1,225,732.20 |
DisclosureSEC source: 0001104659-05-006833 · a4.xml · nonDerivative · entry 2 DE LASA JOSE M · CIK 0001239418 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,001 Read SEC document |
| February 14, 2005 Filed Feb 16, 2005 00:54 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 31,922 | $33.23 | $1,060,812.75 |
DisclosureSEC source: 0001104659-05-006833 · a4.xml · nonDerivative · entry 1 DE LASA JOSE M · CIK 0001239418 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,532 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2005 Filed Feb 4, 2005 19:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 2,194 | $0.00 Strike: $45.55 | $0.00 |
DisclosureSEC source: 0001104659-05-004072 · a4.xml · derivative · entry 5 DE LASA JOSE M · CIK 0001239418 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,194 Underlying: common shares · 2,194 shares Expires 2008-02-12 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 02, 2005 Filed Feb 4, 2005 19:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 2,875 | $0.00 Strike: $34.77 | $0.00 |
DisclosureSEC source: 0001104659-05-004072 · a4.xml · derivative · entry 4 DE LASA JOSE M · CIK 0001239418 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 2,875 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 02, 2005 Filed Feb 4, 2005 19:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 2,194 | $45.55 | $99,936.70 |
DisclosureSEC source: 0001104659-05-004072 · a4.xml · nonDerivative · entry 2 DE LASA JOSE M · CIK 0001239418 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,610 Read SEC document |
| February 02, 2005 Filed Feb 4, 2005 19:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 2,875 | $34.77 | $99,971.51 |
DisclosureSEC source: 0001104659-05-004072 · a4.xml · nonDerivative · entry 1 DE LASA JOSE M · CIK 0001239418 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,804 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2004 Filed Feb 24, 2004 21:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 55,000 | $0.00 Strike: $43.66 | $0.00 |
DisclosureSEC source: 0001104659-04-005602 · a4.xml · derivative · entry 3 DE LASA JOSE M · CIK 0001239418 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: common shares · 55,000 shares Expires 2014-02-19 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16b under Rule 16b-3. The option becomes exercisable in annual increments of 18,334 on 2/20/05, 18,333 on 2/20/06 and 18,333 on 2/20/07. Read SEC document |
| February 20, 2004 Filed Feb 24, 2004 21:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 8,000 | $43.66 | $349,280.00 |
DisclosureSEC source: 0001104659-04-005602 · a4.xml · nonDerivative · entry 1 DE LASA JOSE M · CIK 0001239418 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,929 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16b under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
| February 17, 2004 Filed Feb 18, 2004 23:04 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy · Derivative | 26,372 | $0.00 Strike: $44.31 | $0.00 |
DisclosureSEC source: 0001104659-04-005012 · a4.xml · derivative · entry 5 DE LASA JOSE M · CIK 0001239418 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,372 Underlying: common shares · 26,372 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 17, 2004 Filed Feb 18, 2004 23:04 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 29,999 | $0.00 Strike: $35.36 | $0.00 |
DisclosureSEC source: 0001104659-04-005012 · a4.xml · derivative · entry 4 DE LASA JOSE M · CIK 0001239418 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,001 Underlying: common shares · 29,999 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2004 Filed Feb 18, 2004 23:04 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 26,372 | $44.31 | $1,168,543.32 |
DisclosureSEC source: 0001104659-04-005012 · a4.xml · nonDerivative · entry 2 DE LASA JOSE M · CIK 0001239418 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,929 Read SEC document |
| February 17, 2004 Filed Feb 18, 2004 23:04 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 29,999 | $35.36 | $1,060,764.64 |
DisclosureSEC source: 0001104659-04-005012 · a4.xml · nonDerivative · entry 1 DE LASA JOSE M · CIK 0001239418 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,301 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2004 Filed Feb 10, 2004 20:44 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 48,000 | $44.25 | $2,124,038.40 |
DisclosureSEC source: 0001104659-04-003280 · a4.xml · nonDerivative · entry 4 DE LASA JOSE M · CIK 0001239418 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,302 Read SEC document |
| January 30, 2004 Filed Feb 10, 2004 20:44 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 490 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-04-003280 · a4.xml · nonDerivative · entry 3 DE LASA JOSE M · CIK 0001239418 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,302 Read SEC document |
| November 25, 2003 Filed Nov 26, 2003 18:08 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 2,242 | $0.00 Strike: $44.58 | $0.00 |
DisclosureSEC source: 0001104659-03-027453 · a4.xml · derivative · entry 8 DE LASA JOSE M · CIK 0001239418 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,242 Underlying: Common shares · 2,242 shares Expires 2010-02-10 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| November 25, 2003 Filed Nov 26, 2003 18:08 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 2,241 | $0.00 Strike: $44.58 | $0.00 |
DisclosureSEC source: 0001104659-03-027453 · a4.xml · derivative · entry 7 DE LASA JOSE M · CIK 0001239418 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,241 Underlying: Common shares · 2,241 shares Expires 2007-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| November 25, 2003 Filed Nov 26, 2003 18:08 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 2,881 | $0.00 Strike: $34.70 | $0.00 |
DisclosureSEC source: 0001104659-03-027453 · a4.xml · derivative · entry 6 DE LASA JOSE M · CIK 0001239418 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 2,881 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 25, 2003 Filed Nov 26, 2003 18:08 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 3,424 | $0.00 Strike: $29.19 | $0.00 |
DisclosureSEC source: 0001104659-03-027453 · a4.xml · derivative · entry 5 DE LASA JOSE M · CIK 0001239418 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 3,424 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 25, 2003 Filed Nov 26, 2003 18:08 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 4,483 | $44.58 | $199,852.14 |
DisclosureSEC source: 0001104659-03-027453 · a4.xml · nonDerivative · entry 3 DE LASA JOSE M · CIK 0001239418 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,612 Read SEC document |
| November 25, 2003 Filed Nov 26, 2003 18:08 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 2,881 | $34.70 | $99,970.70 |
DisclosureSEC source: 0001104659-03-027453 · a4.xml · nonDerivative · entry 2 DE LASA JOSE M · CIK 0001239418 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,095 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 25, 2003 Filed Nov 26, 2003 18:08 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 3,424 | $29.19 | $99,946.56 |
DisclosureSEC source: 0001104659-03-027453 · a4.xml · nonDerivative · entry 1 DE LASA JOSE M · CIK 0001239418 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,214 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2003 Filed Sep 16, 2003 18:44 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 23,776 | $0.00 Strike: $43.57 | $0.00 |
DisclosureSEC source: 0001104659-03-020783 · a4.xml · derivative · entry 6 DE LASA JOSE M · CIK 0001239418 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,776 Underlying: common shares · 23,776 shares Expires 2010-02-10 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| September 12, 2003 Filed Sep 16, 2003 18:44 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 27,119 | $0.00 Strike: $34.70 | $0.00 |
DisclosureSEC source: 0001104659-03-020783 · a4.xml · derivative · entry 5 DE LASA JOSE M · CIK 0001239418 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,881 Underlying: common shares · 27,119 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2003 Filed Sep 16, 2003 18:44 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Salecommon shares without par value | 3,343 | $43.37 | $144,985.91 |
DisclosureSEC source: 0001104659-03-020783 · a4.xml · nonDerivative · entry 3 DE LASA JOSE M · CIK 0001239418 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,790 Read SEC document |
| September 12, 2003 Filed Sep 16, 2003 18:44 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingcommon shares without par value | 23,776 | $43.57 | $1,035,920.32 |
DisclosureSEC source: 0001104659-03-020783 · a4.xml · nonDerivative · entry 2 DE LASA JOSE M · CIK 0001239418 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,133 Read SEC document |
| September 12, 2003 Filed Sep 16, 2003 18:44 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversioncommon shares without par value | 27,119 | $34.70 | $941,029.30 |
DisclosureSEC source: 0001104659-03-020783 · a4.xml · nonDerivative · entry 1 DE LASA JOSE M · CIK 0001239418 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,909 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 10, 2003 Filed Feb 10, 2004 20:44 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 4,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-04-003280 · a4.xml · nonDerivative · entry 2 DE LASA JOSE M · CIK 0001239418 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,792 Read SEC document |
| March 11, 2003 Filed Feb 10, 2004 20:44 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 170 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-04-003280 · a4.xml · nonDerivative · entry 1 DE LASA JOSE M · CIK 0001239418 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,442 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.